Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Boston Scientific Corp (BSX)  
$73.17 0.09 (0.12%) as of 4:30 Fri 4/26


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 1,430,000,000
Market Cap: 104.63(B)
Last Volume: 8,786,292 Avg Vol: 8,469,733
52 Week Range: $48.64 - $73.26
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Instruments & Supplies

Member Indexes:

    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  297
Guru Rank Value     : 4.1
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 86,763 367,796 891,893 1,852,495
Total Sell Value $5,815,387 $21,391,604 $49,075,093 $90,475,166
Total People Sold 6 8 11 13
Total Sell Transactions 9 19 36 69
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 1823
  Page 13 of 73  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Nanavaty Maulik SVP & Pres, Neuromodulation   •       •      –    2013-02-24 4 D $7.37 $5,704 D/D (774) 70,820     -
   Nanavaty Maulik SVP & Pres, Neuromodulation   •       •      –    2013-02-24 4 OE $0.00 $0 D/D 2,109 71,594     -
   Pierce David A SVP and President, Endoscopy   •       •      –    2013-02-24 4 D $7.37 $7,038 D/D (955) 18,202     -
   Pierce David A SVP and President, Endoscopy   •       •      –    2013-02-24 4 OE $0.00 $0 D/D 3,012 19,157     -
   Dawkins Keith D EVP, Global Chief Med. Off.   •       •      –    2013-02-24 4 D $7.37 $5,631 D/D (764) 72,606     -
   Dawkins Keith D EVP, Global Chief Med. Off.   •       •      –    2013-02-24 4 OE $0.00 $0 D/D 2,410 73,370     -
   Pucel Kenneth EVP, Glob Ops, Qual & Tech   •       •      –    2013-02-24 4 D $7.37 $7,259 D/D (985) 116,694     -
   Pucel Kenneth EVP, Glob Ops, Qual & Tech   •       •      –    2013-02-24 4 OE $0.00 $0 D/D 3,012 117,679     -
   Carruthers Wendy SVP, Human Resources   •       •      –    2013-02-24 4 D $7.37 $7,038 D/D (955) 39,137     -
   Carruthers Wendy SVP, Human Resources   •       •      –    2013-02-24 4 OE $0.00 $0 D/D 3,012 40,092     -
   Capello Jeffrey D EVP & Chief Financial Officer   •       •      –    2013-02-23 4 D $7.37 $19,383 D/D (2,630) 162,782     -
   Capello Jeffrey D EVP & Chief Financial Officer   •       •      –    2013-02-23 4 OE $0.00 $0 D/D 8,065 165,412     -
   Lance Jean Fitterer SVP & Chief Compliance Officer   •       •      –    2013-02-16 4 D $7.54 $13,466 D/D (1,786) 76,831     -
   Lance Jean Fitterer SVP & Chief Compliance Officer   •       •      –    2013-02-16 4 OE $0.00 $0 D/D 4,589 78,617     -
   Pierce David A SVP and President, Endoscopy   •       •      –    2013-02-16 4 D $7.54 $14,560 D/D (1,931) 16,145     -
   Pierce David A SVP and President, Endoscopy   •       •      –    2013-02-16 4 OE $0.00 $0 D/D 5,122 18,076     -
   Phalen Michael P. EVP & President, MedSurg   •       •      –    2013-02-16 4 D $7.54 $12,554 D/D (1,665) 65,958     -
   Phalen Michael P. EVP & President, MedSurg   •       •      –    2013-02-16 4 OE $0.00 $0 D/D 4,724 67,623     -
   Dawkins Keith D EVP, Global Chief Med. Off.   •       •      –    2013-02-16 4 D $7.54 $8,068 D/D (1,070) 70,960     -
   Dawkins Keith D EVP, Global Chief Med. Off.   •       •      –    2013-02-16 4 OE $0.00 $0 D/D 3,374 72,030     -
   Fitzgerald Joseph Michael SVP & President, CRM   •       •      –    2013-02-16 4 D $7.54 $13,859 D/D (1,838) 83,848     -
   Fitzgerald Joseph Michael SVP & President, CRM   •       •      –    2013-02-16 4 OE $0.00 $0 D/D 4,724 85,686     -
   Nanavaty Maulik SVP & Pres, Neuromodulation   •       •      –    2013-02-16 4 D $7.54 $7,005 D/D (929) 69,485     -
   Nanavaty Maulik SVP & Pres, Neuromodulation   •       •      –    2013-02-16 4 OE $0.00 $0 D/D 2,116 70,414     -
   Carruthers Wendy SVP, Human Resources   •       •      –    2013-02-16 4 D $7.54 $10,722 D/D (1,422) 37,080     -

  1823 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 13 of 73
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed